The Molecular Imaging Probes and Contrast Agents Database has included 17 new agents on its list, bringing the total number of agents in the database to 841. The new agents are for PET, SPECT and optical imaging.
A Dutch study involving rectal cancer patients found that CT perfusion results following hypofractionated radiotherapy correlated with FDG-PET results in showing increased tumor perfusion. The findings indicate that PET/CT can be used to assess the early effects of the radiotherapeutic procedure in this patient group, a researcher said.
The Molecular Imaging and Contrast Agent Database has added nine new agents to its list, including agents for SPECT, PET, magnetic resonance and optical imaging. The database currently has 814 agents. The MICAD guest author program also is calling on imaging community members to forward write-ups on various agents for publication.
The NIH's Molecular imaging and contrast agent database has added 13 imaging agents for PET, SPECT and MRI. MICAD is part of the NIH Roadmap's Molecular Libraries and Imaging program. It now includes 796 agents.